Latest Conference Articles

May 16th 2012, 2:01pm

ASCO Annual Meeting

Dr. Maurie Markman, Cancer Treatment Centers of America, on Primary Care Physician Awareness of Long-Term Chemotherapy Side Effects

May 16th 2012, 2:01pm

ASCO Annual Meeting

Many primary care providers and some oncologists are unaware of the long-term effects of four chemotherapy drugs used to treat two of the most common forms of cancer.

May 16th 2012, 2:00pm

ASCO Annual Meeting

Dr. Andre Goy, from John Theurer Cancer Center, on Crizotinib for Pediatric Patients With ALCL

May 16th 2012, 2:00pm

ASCO Annual Meeting

Targeting the ALK gene with the oral agent crizotinib slowed or eliminated signs of tumor growth in pediatric patients with aggressive forms of neuroblastoma, ALCL, and IMTs.

May 16th 2012, 12:02pm

ASCO Annual Meeting

Dr. Shayma Kazmi, from Cancer Treatment Centers of America, on Olanzapine for Breakthrough Chemotherapy-Induced Nausea and Vomiting

May 10th 2012, 1:40pm

Oncology Nursing Society Congress

Five nurses discuss the value of the Oncology Nursing Society (ONS) Annual Congress, which is the largest meeting held specifically for oncology nurses.

May 8th 2012, 10:38am

Oncology Nursing Society Congress

The Oncology Nursing Society (ONS) 37th Annual Congress video highlights, from OncLive TV.

May 7th 2012, 1:29pm

Oncology Nursing Society Congress

The Oncology Nursing Society (ONS) 37th Annual Congress Picture Slideshow.

May 7th 2012, 12:40pm

Oncology Nursing Society Congress

A recap of our coverage from the Oncology Nursing Society 37th Annual Congress, in New Orleans, where thousands of oncology nurses gathered and shared valuable clinical insights.

May 7th 2012, 12:25pm

Oncology Nursing Society Congress

Mary Gullatte, the president of the Oncology Nursing Society, Discusses Nursing Shortages

May 7th 2012, 12:24pm

Oncology Nursing Society Congress

Carol Bush, BS, RN, from the The University of Kansas Cancer Center, on the Midwest Cancer Alliance Telehealth Network

May 7th 2012, 12:13pm

Oncology Nursing Society Congress

Universal tumor testing and a detailed personal and family history assessment are recommended for all patients with newly diagnosed colorectal cancer.

May 6th 2012, 4:00pm

Oncology Nursing Society Congress

Erin McMenamin, MSN, from the Hospital of the University of Pennsylvania, on HPV-related Head & Neck Cancer Prognosis

May 6th 2012, 7:00am

Oncology Nursing Society Congress

The chemotherapy safety standards developed by ASCO and ONS were recently updated to reflect the fact that chemotherapy is delivered in a variety of settings.

May 6th 2012, 6:00am

Oncology Nursing Society Congress

Krista Rubin, MS, RN, FNP-BC, from Massachusetts General Hospital Cancer Center, on Managing Ipilimumab-related Dermatitis.

May 6th 2012, 5:00am

Oncology Nursing Society Congress

Standards for identifying appropriate populations for treatment with HER2-targeted therapies are evolving.

May 5th 2012, 2:40pm

Oncology Nursing Society Congress

Michael Eckenfels, RN, OCN, from MD Anderson Cancer Center, on Changes to the Bortezomib Delivery Route.

May 5th 2012, 2:06pm

Oncology Nursing Society Congress

Anna Vioral, RN, OCN, from West Penn Allegheny Health System, on Multidisciplinary Chemotherapy Safety Standards.

May 5th 2012, 8:22am

Oncology Nursing Society Congress

All oncology nurses-not just nurse researchers-will need to understand the fundamentals of clinical trials as patient access to the studies continues to expand.

May 5th 2012, 8:13am

Oncology Nursing Society Congress

Treatment of head and neck cancer often leaves patients with aftereffects that are bothersome at the very least and life-altering at their worst.